1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ASTRAZENECA PLC - ADR
Astrazeneca plc - ADR XNAS: AZN

Astrazeneca plc - ADR Live Stock Price Today, Share Analysis and Chart

Turnaround Potential
about

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and m...

Read More
88.61 0.93 (1.06%)
New 52W High today
4.5M
XNAS Volume

XNAS 13 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Mid Valuation
33.2 / 100
Momentum Score
Technically Moderately Bullish
69.6 / 100
Turnaround Potential These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors. View Similar Embed DVM
Analyst Price Target
93
1Yr Price target upside is 5%
11 analysts

16

S

4

W

1

O

3

T

SWOT Analysis

Astrazeneca plc ADR Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..